Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Apitolisib
Trade Name
Synonyms GDC-0980
Drug Descriptions

Apitolisib (GDC-0980) is an inhibitor of both PI3K and mTOR kinases, resulting in decreased phosphorylation of PI3K/Akt/mTOR pathway markers, which may lead to inhibition of tumor growth and tumor regression (PMID: 21998291, PMID: 30914027).

DrugClasses mTOR Inhibitor 51 PI3K Inhibitor (Pan) 42
CAS Registry Number 1032754-93-0
NCIT ID C91731

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Ado-trastuzumab emtansine + Apitolisib Ado-trastuzumab emtansine Apitolisib 0 0
Apitolisib Apitolisib 11 3
Apitolisib + Palbociclib Apitolisib Palbociclib 0 0
Apitolisib + PD-0325901 Apitolisib PD-0325901 0 0
Apitolisib + Trastuzumab Apitolisib Trastuzumab 0 0


Additional content available in CKB BOOST